Go back

Qdossier Qsauri
"S"

supplement type
Guideline or reference source
FDA www.fda.gov
Definition
Companies are allowed to make changes to drugs or their labels after they have been approved. To change a label, market a new dosage or strength of a drug, or change the way it manufactures a drug, a company must submit a supplemental new drug application (sNDA). The supplement type refers to the kind of change that was approved by FDA. This includes changes in manufacturing, patient population, and formulation.
Related Term
supplement
supplement to a new drug submission
 

Send comments to info@qdossier.com Please read disclaimer before using Qsauri.